Malignant Hyperthermia

Overview

Journal Can Anaesth Soc J

Specialty Anesthesiology

Date 1985 Nov 1

PMID 4075218

Citations 18

Authors

B A Britt

Affiliations

Soon will be listed here.

Citing Articles

Round Table on Malignant Hyperthermia in Physically Active Populations: Meeting Proceedings.

Hosokawa Y, Casa D, Rosenberg H, Capacchione J, Sagui E, Riazi S J Athl Train. 2017; 52(4):377-383.

PMID: 28430550 PMC: 5402536. DOI: 10.4085/1062-6050-52.2.06.

Malignant hyperthermia: a review.

Rosenberg H, Pollock N, Schiemann A, Bulger T, Stowell K Orphanet J Rare Dis. 2015; 10:93.

PMID: 26238698 PMC: 4524368. DOI: 10.1186/s13023-015-0310-1.

Postoperative hyperpyrexia: Retracing malignant hyperthermia.

Gupta D, Ramakant , Singh P J Anaesthesiol Clin Pharmacol. 2012; 28(3):405-6.

PMID: 22869961 PMC: 3409964. DOI: 10.4103/0970-9185.98370.

A case of malignant hyperthermia during anesthesia induction with sevoflurane -A case report-.

Lee Y, Kim W, Lee S, Baek S, Ok S, Kim J Korean J Anesthesiol. 2011; 59 Suppl:S6-8.

PMID: 21286462 PMC: 3030058. DOI: 10.4097/kjae.2010.59.S.S6.

Malignant hyperthermia.

Rosenberg H, Davis M, James D, Pollock N, Stowell K Orphanet J Rare Dis. 2007; 2:21.

PMID: 17456235 PMC: 1867813. DOI: 10.1186/1750-1172-2-21.

References

KALOW W, Britt B, Chan F . Epidemiology and inheritance of malignant hyperthermia. Int Anesthesiol Clin. 1979; 17(4):119-39. DOI: 10.1097/00004311-197917040-00008. View

Britt B . Dantrolene. Can Anaesth Soc J. 1984; 31(1):61-75. DOI: 10.1007/BF03011484. View

Britt B, Frodis W, Scott E, Clements M, Endrenyi L . Comparison of the caffeine skinned fibre tension (CSFT) test with the caffeine-halothane contracture (CHC) test in the diagnosis of malignant hyperthermia. Can Anaesth Soc J. 1982; 29(6):550-62. DOI: 10.1007/BF03007740. View

Mabuchi K, SRETER F . Use of cryostat sections for measurement of Ca2+ uptake by sarcoplasmic reticulum. Anal Biochem. 1978; 86(2):733-42. DOI: 10.1016/0003-2697(78)90801-1. View

Britt B, Endrenyi L, KALOW W, Peters P . The adenosine triphosphate (ATP) depletion test: comparison with the caffeine contracture test as a method of diagnosing malignant hyperthermia susceptibility. Can Anaesth Soc J. 1976; 23(6):624-35. DOI: 10.1007/BF03006745. View

Harriman D . Preanesthetic investigation of malignant hyperthermia: microscopy. Int Anesthesiol Clin. 1979; 17(4):97-117. DOI: 10.1097/00004311-197917040-00007. View

Britt B, Endrenyi L, Peters P, Kwong F, Kadijevic L . Screening of malignant hyperthermia susceptible families by creatine phosphokinase measurement and other clinical investigations. Can Anaesth Soc J. 1976; 23(3):263-84. DOI: 10.1007/BF03005702. View

Niebroj-Dobosz I, Kwiatkowski H, Mayzner-Zawadzka E . Experimental porcine malignant hyperthermia: macromolecular characterization of muscle plasma membranes. Med Biol. 1984; 62(4):250-4. View

Lopez J, Alamo L, Caputo C, Wikinski J, Ledezma D . Intracellular ionized calcium concentration in muscles from humans with malignant hyperthermia. Muscle Nerve. 1985; 8(5):355-8. DOI: 10.1002/mus.880080502. View

10.

Gronert G, Thompson R, Onofrio B . Human malignant hyperthermia: awake episodes and correction by dantrolene. Anesth Analg. 1980; 59(5):377-8. View

11.

Nelson T . Abnormality in calcium release from skeletal sarcoplasmic reticulum of pigs susceptible to malignant hyperthermia. J Clin Invest. 1983; 72(3):862-70. PMC: 1129251. DOI: 10.1172/JCI111057. View

12.

Flewellen E, Nelson T . Masseter spasm induced by succinylcholine in children: contracture testing for malignant hyperthermia: report of six cases. Can Anaesth Soc J. 1982; 29(1):42-9. DOI: 10.1007/BF03007947. View

13.

Citino S, Bush M, PHILLIPS L . Dystocia and fatal hyperthermic episode in a giraffe. J Am Vet Med Assoc. 1984; 185(11):1440-2. View

14.

Gronert G . Malignant hyperthermia. Anesthesiology. 1980; 53(5):395-423. DOI: 10.1097/00000542-198011000-00007. View

15.

KOLB M, Horne M, Martz R . Dantrolene in human malignant hyperthermia. Anesthesiology. 1982; 56(4):254-62. DOI: 10.1097/00000542-198204000-00005. View

16.

Amaranath L, Lavin T, Trusso R, BOUTROS A . Evaluation of creatinine phosphokinase screening as a predictor of malignant hyperthermia. A prospective study. Br J Anaesth. 1983; 55(6):531-3. DOI: 10.1093/bja/55.6.531. View

17.

Birkhimer L, DeVane C . The neuroleptic malignant syndrome: presentation and treatment. Drug Intell Clin Pharm. 1984; 18(6):462-5. DOI: 10.1177/106002808401800601. View

18.

Britt B, KALOW W . Malignant hyperthermia: a statistical review. Can Anaesth Soc J. 1970; 17(4):293-315. DOI: 10.1007/BF03004694. View

19.

Kim D, SRETER F, Ohnishi S, Ryan J, Roberts J, Allen P . Kinetic studies of Ca2+ release from sarcoplasmic reticulum of normal and malignant hyperthermia susceptible pig muscles. Biochim Biophys Acta. 1984; 775(3):320-7. DOI: 10.1016/0005-2736(84)90187-1. View

20.

Britt B . Etiology and pathophysiology of malignant hyperthermia. Fed Proc. 1979; 38(1):44-8. View